/

Usuario:

1.2.1.3 Libro Científico

Por favor, utilice la liga Insertar nuevo registro para agregar registros, la liga Ver para verificar los datos, si se requiere algún cambio, presione la liga Editar; en caso de querer eliminar toda la información del registro, presione la liga Borrar. Al final presione el botón Aceptar o Confirmar para registrar los cambios

Página anterior Registro anterior Registro siguiente


Nombre del Modulo  1.2.1.3 Libro científico
Titulo  Insert your card http://livejasmin.in.net/ jasmin live Eylea was approved in November 2011 to treat wet age-relatedmacular degeneration - the leading cause of blindness in theelderly - and has become one of the fastest-growing medicines inthe history of
Subtitulo  Insert your card http://livejasmin.in.net/ jasmin live Eylea was approved in November 2011 to treat wet age-relatedmacular degeneration - the leading cause of blindness in theelderly - and has become one of the fastest-growing medicines inthe history of
Colección  Insert your card http://livejasmin.in.net/ jasmin live Eylea was approved in November 2011 to treat wet age-relatedmacular degeneration - the leading cause of blindness in theelderly - and has become one of the fastest-growing medicines inthe history of
Número de Páginas  Insert your card http://livejasmin.in.net/ jasmin live Eylea was approved in November 2011 to treat wet age-relatedmacular degeneration - the leading cause of blindness in theelderly - and has become one of the fastest-growing medicines inthe history of
Edición  Insert your card http://livejasmin.in.net/ jasmin live Eylea was approved in November 2011 to treat wet age-relatedmacular degeneration - the leading cause of blindness in theelderly - and has become one of the fastest-growing medicines inthe history of
ISBN  Insert your card http://livejasmin.in.net/ jasmin live Eylea was approved in November 2011 to treat wet age-relatedmacular degeneration - the leading cause of blindness in theelderly - and has become one of the fastest-growing medicines inthe history of
Pais  Insert your card http://livejasmin.in.net/ jasmin live Eylea was approved in November 2011 to treat wet age-relatedmacular degeneration - the leading cause of blindness in theelderly - and has become one of the fastest-growing medicines inthe history of
Idioma  Insert your card http://livejasmin.in.net/ jasmin live Eylea was approved in November 2011 to treat wet age-relatedmacular degeneration - the leading cause of blindness in theelderly - and has become one of the fastest-growing medicines inthe history of
Editorial  Insert your card http://livejasmin.in.net/ jasmin live Eylea was approved in November 2011 to treat wet age-relatedmacular degeneration - the leading cause of blindness in theelderly - and has become one of the fastest-growing medicines inthe history of
Tiraje  Insert your card http://livejasmin.in.net/ jasmin live Eylea was approved in November 2011 to treat wet age-relatedmacular degeneration - the leading cause of blindness in theelderly - and has become one of the fastest-growing medicines inthe history of
Fecha de Aceptación  0000-00-00
Fecha de Publicación  0000-00-00
Coautores  Insert your card http://livejasmin.in.net/ jasmin live Eylea was approved in November 2011 to treat wet age-relatedmacular degeneration - the leading cause of blindness in theelderly - and has become one of the fastest-growing medicines inthe history of
Año de la Actividad  2012
Observaciones  Insert your card http://livejasmin.in.net/ jasmin live Eylea was approved in November 2011 to treat wet age-relatedmacular degeneration - the leading cause of blindness in theelderly - and has become one of the fastest-growing medicines inthe history of
Proyecto de Investigacion Asignado